scholarly journals Plasminogen Activator Inhibitor-1 and Relations to Fatty Acid Composition in the Diet and in Serum Cholesterol Esters

2001 ◽  
Vol 21 (12) ◽  
pp. 2086-2092 ◽  
Author(s):  
Liisa Byberg ◽  
Annika Smedman ◽  
Bengt Vessby ◽  
Hans Lithell
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Plasminogen Activator ◽  
Acid Composition ◽  
Serum Cholesterol ◽  
Plasminogen Activator Inhibitor ◽  
Cholesterol Esters ◽  
Plasminogen Activator Inhibitor 1 ◽  
Activator Inhibitor

The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters

Diabetes ◽  
1994 ◽  
Vol 43 (11) ◽  
pp. 1353-1357 ◽  
Author(s):  
B. Vessby ◽  
A. Aro ◽  
E. Skarfors ◽  
L. Berglund ◽  
I. Salminen ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Serum Cholesterol ◽  
Cholesterol Esters

Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: A population-based study

Metabolism ◽  
1990 ◽  
Vol 39 (12) ◽  
pp. 1285-1291 ◽  
Author(s):  
V. Salomaa ◽  
I. Ahola ◽  
J. Tuomilehto ◽  
A. Aro ◽  
P. Pietinen ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Glucose Intolerance ◽  
Serum Cholesterol ◽  
Population Based ◽  
Cholesterol Esters ◽  
Population Based Study

scholarly journals Soluble-fibre concentrate lowers plasminogen activator inhibitor-1 in baboons (Papio ursinus)

1997 ◽  
Vol 78 (4) ◽  
pp. 625-637 ◽  
Author(s):  
C. S. Venter ◽  
C. J. Nel ◽  
H. H. Vorster ◽  
J. C. Jerling ◽  
W. Oosthuizen ◽  
...  
Keyword(s):  
Plasminogen Activator ◽  
Serum Cholesterol ◽  
Plasminogen Activator Inhibitor ◽  
Lipid Lowering ◽  
Total Serum ◽  
Total Serum Cholesterol ◽  
Plasminogen Activator Inhibitor 1 ◽  
Papio Ursinus ◽  
Activator Inhibitor ◽  
Pai 1

The effects of a soluble NSP (fibre) concentrate (SFC) on plasma fibrinogen and plasminogen activator inhibitor-1 (PAI-1), serum and liver lipids and lipoproteins and glucose tolerance were compared with those of bezafibrate (BF), a lipid-lowering drug, in obese baboons (Papio ursinus) The basal diet was a high-fat (37% of total energy), low-NSP (12.4 g/d) Westernized diet, supplemented for 8 weeks with either 20 SFCg/baboon per d or 6.7 mg BF/kg body weight per baboon per d. SFC supplementation significantly lowered PAI-1, total serum cholesterol, HDL-cholesterol and circulating free fatty acid levels. BF significantly lowered total serum cholesterol, but unexpectedly raised serum triacylglycerol levels. Although not statistically significant, the mean liver tricacylglycerol concentration of baboons fed on BF was lower than that of baboons fed on SFC supplements. These results suggest that: (1) the mechanism of action of the two cholesterol-lowering treatments differ, with BF having a liver triacylglycerol-lowering effect and (2) the SFC had additional beneficial effect on fibrinolysis by lowering PAI-1 levels.

The Risk to Develop NIDDM Is Related to the Fatty Acid Composition of the Serum Cholesterol Esters

Diabetes ◽  
1994 ◽  
Vol 43 (11) ◽  
pp. 1353-1357 ◽  
Author(s):  
B. Vessby ◽  
A. Aro ◽  
E. Skarfors ◽  
L. Berglund ◽  
I. Salminen ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Serum Cholesterol ◽  
Cholesterol Esters
Sign in / Sign up

Export Citation Format

Share Document